{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T10:41:17Z","timestamp":1684060877004},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T00:00:00Z","timestamp":1191974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s00115-007-2343-8","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T02:19:23Z","timestamp":1191896363000},"page":"86-89","source":"Crossref","is-referenced-by-count":3,"title":["Malignes neuroleptisches Syndrom durch Amisulprid","Malignant neuroleptic syndrome associated with amisulpride"],"prefix":"10.1007","volume":"79","author":[{"given":"C.","family":"Harter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Obier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-F.","family":"Druschky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Eikelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,10]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.4088\/JCP.v65n1219f","volume":"65","author":"Altbasoglu","year":"2004","unstructured":"Altbasoglu EC, Ozguven HD, Saka MC, Goker C (2004) Rhabdomyolysis and coma associated with amislupride: A probable atypical presentation of neuroleptic malignant syndrome. J Clin Psychiatry 65: 1724\u20131725","journal-title":"J Clin Psychiatry"},{"key":"2343_CR2","unstructured":"American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington DC"},{"key":"2343_CR3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","volume":"65","author":"Ananth","year":"2004","unstructured":"Ananth J, Parameswaran S, Gunatilake S et al. (2004) Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 65: 464\u2013470","journal-title":"J Clin Psychiatry"},{"key":"2343_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s004060050043","volume":"248","author":"Assion","year":"1998","unstructured":"Assion HJ, Heinemann F, Laux G (1998) Neuroleptic malignant syndrome under treatment with antidepressants? A critical review. Eur Arch Psychiatry Clin Neurosci 248: 231\u2013239","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2343_CR5","doi-asserted-by":"crossref","unstructured":"Assion HJ, Volz HP (2004) Malignes neuroleptisches Syndrom. Thieme, Stuttgart New York","DOI":"10.1055\/b-002-19473"},{"key":"2343_CR6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2005-837770","volume":"38","author":"Baumgart","year":"2005","unstructured":"Baumgart U, Schmidt R, Spie\u00dfl H (2005) Olanzapine-induced acute rhabdomyolysis. Pharamcopsychiatry 38: 36\u201337","journal-title":"Pharamcopsychiatry"},{"key":"2343_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0733-8619(05)70338-8","volume":"15","author":"Bertorini","year":"1997","unstructured":"Bertorini T (1997) Myoglobinuria, malignant hyperthermia, neuroleptic malignant syndrom and serotonin syndrome. Neurol Clin 15: 649\u2013671","journal-title":"Neurol Clin"},{"key":"2343_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2002-31518","volume":"35","author":"Bottlender","year":"2002","unstructured":"Bottlender R, J\u00e4ger M, Hofschuster E et al. (2002) Neuroleptic malignant syndrome due to atypical neuroleptics: Three episodes in one patient. Pharmacopsychiatry 35: 119\u2013121","journal-title":"Pharmacopsychiatry"},{"key":"2343_CR9","first-page":"111","volume":"7","author":"Davis","year":"1997","unstructured":"Davis JM, Janicak PG, Sakkas P et al. (1997) Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convuls Ther 7: 111\u2013120","journal-title":"Convuls Ther"},{"key":"2343_CR10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/ajp.147.9.1149","volume":"147","author":"Deng","year":"1990","unstructured":"Deng MZ, Chen GQ, Philiphs MR (1990) Neuroleptic malignant syndrome in 12 of 9.792 Chinese inpatients exposed to neuroleptics: a prospective study. Am J Psychiatry 147: 1149\u20131155","journal-title":"Am J Psychiatry"},{"key":"2343_CR11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/ajp.156.2.169","volume":"156","author":"Gurrera","year":"1999","unstructured":"Gurrera RJ (1999) Sympathoadrenal hyperactivity and the etiology of neuroleptic syndrome. Am J Psychiatry 156: 169\u2013180","journal-title":"Am J Psychiatry"},{"key":"2343_CR12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s004060050036","volume":"248","author":"Hatta","year":"1998","unstructured":"Hatta K, Takahashi T, Nakamura H et al. (1998) Abnormal physiological conditions in acute schizophrenic patients on emergency admission: dehydration, hypokalemia, leukocytosis and elevated serum muscle enzymes. Eur Arch Psychiatry Clin Neurosci 248: 180\u2013188","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2343_CR13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/070674379303800116","volume":"38","author":"McElroy","year":"1993","unstructured":"McElroy SL, Keck PE (1993) Treatment guidelines for valproate in bipolar and schizoaffective disorders. Can J Psychiatry 38: 62\u201366","journal-title":"Can J Psychiatry"},{"key":"2343_CR14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0893-133X(95)00276-J","volume":"15","author":"Meltzer","year":"1996","unstructured":"Meltzer HY, Cola PA, Parsa M (1996) Marked elevations of serum creatine kinase activity assoicated with antipsychotic drug treatment. Neuropsychopharmacology 15: 395\u2013405","journal-title":"Neuropsychopharmacology"},{"key":"2343_CR15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s00702-002-0762-z","volume":"109","author":"Northoff","year":"2002","unstructured":"Northoff G (2002) Catatonia and neuroleptic malignant syndrom: psychopathology and pathophysiology. J Neural Transm 109: 1453\u20131467","journal-title":"J Neural Transm"},{"key":"2343_CR16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0924-9338(00)00402-8","volume":"15","author":"Spivak","year":"2000","unstructured":"Spivak B, Maline DI, Kozyrev VN et al. (2000) Frequency of neuroleptic malignant syndrom in a large psychiatric hospital in Moscow. Eur Psychiatry 15: 330\u2013333","journal-title":"Eur Psychiatry"},{"key":"2343_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0447.2003.02385.x","volume":"107","author":"Viejo","year":"2003","unstructured":"Viejo LF, Morales V, Punal P et al. (2003) Risk factors in neuroleptic malignant syndrome. A case-control study. Acta Psychiatr Scand 107: 45\u201349","journal-title":"Acta Psychiatr Scand"},{"key":"2343_CR18","first-page":"645","volume":"63","author":"Weller","year":"1992","unstructured":"Weller M, Kornhuber J (1992) Pathophysiologie und Therapie des Malignen Neuroleptischen Syndroms. Nervenarzt 63: 645\u2013655","journal-title":"Nervenarzt"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-007-2343-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-007-2343-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-007-2343-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T10:24:17Z","timestamp":1684059857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-007-2343-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,10]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1007\/s00115-007-2343-8","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,10]]}}}